Literature DB >> 19169089

Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases.

Deepak Gupta1, Gupta Deepak, Muraleedharan Nair, Nair Muraleedharan, Neeraj N Baheti, P Sankara Sarma, Sankara P Sarma, Abraham Kuruvilla, Kuruvilla Abraham.   

Abstract

BACKGROUND: The incidence of Guillain-Barré syndrome (GBS) and its subtypes varies throughout the world. OBJECTIVE AND METHODS: We present a retrospective analysis of 142 GBS cases, treated at our center, aimed at classifying GBS electrophysiologically, to study the sequential electrophysiological changes in cases with acute inflammatory demyelinating polyradiculoneuropathy (AIDP), and to look for any clinical and cerebrospinal fluid parameters that can also help in distinguishing the subtypes.
RESULTS: One hundred twenty-one (85.2%) cases had AIDP, 15 (10.6%) had acute motor axonal neuropathy, and 6 (4.2%) were unclassifiable.
CONCLUSIONS: Motor conduction blocks and temporal dispersion could be observed from days 3 and 5 onward, respectively. Progression of motor conduction slowing in AIDP was most impressive in the median nerves. Varying affection of deep tendon reflexes, cranial nerves, and cerebrospinal fluid albuminocytological dissociation can also help make a distinction between AIDP and acute motor axonal neuropathy. Sural sparing, a marker of demyelinating neuropathy, is more commonly seen in later than in early stages of AIDP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19169089     DOI: 10.1097/CND.0b013e31818e9510

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  11 in total

1.  Further insight on A-wave in acute and chronic demyelinating neuropathies.

Authors:  Ferdinando Sartucci; Tommaso Bocci; Davide Borghetti; Giovanni Orlandi; Francesco Manfredonia; Luigi Murri; Fabio Giannini; Alessandro Rossi
Journal:  Neurol Sci       Date:  2010-06-18       Impact factor: 3.307

2.  Hyperreflexic Guillain-Barré syndrome.

Authors:  Neeraj N Baheti; Davis Manuel; Pranav D Shinde; Ashalatha Radhakrishnan; Muraleedharan Nair
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

3.  Clinical features and prognosis with Guillain-Barré syndrome.

Authors:  Sinan Akbayram; Murat Doğan; Cihangir Akgün; Erdal Peker; Refah Sayιn; Fesih Aktar; Mehmet-Selçuk Bektaş; Hüseyin Caksen
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

4.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

5.  Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome.

Authors:  Samira Yadegari; Shahriar Nafissi; Neda Kazemi
Journal:  Iran J Neurol       Date:  2014-07-04

6.  Guillain-Barre syndrome: Demographics, clinical profile & seasonal variation in a tertiary care centre of central India.

Authors:  Manisha Shrivastava; Shah Nehal; Navaid Seema
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

7.  Severe Acute Axonal Neuropathy Induced by Ciprofloxacin: A Case Report.

Authors:  Cyprian Popescu
Journal:  Case Rep Neurol       Date:  2018-05-30

8.  Clinical predictors and electrodiagnostic characteristics in patients with Guillain-Barré syndrome with respiratory failure: a retrospective, matched case-control study.

Authors:  Kanchana Charoentanyarak; Apiradee Singjam; Jittima Saengsuwan
Journal:  PeerJ       Date:  2022-02-10       Impact factor: 2.984

Review 9.  Epidemiology of Peripheral Neuropathy: An Indian Perspective.

Authors:  Sweety Trivedi; Alak Pandit; Goutam Ganguly; Shyamal Kumar Das
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383

10.  Epidemiology and Clinical Features of Guillain-Barre Syndrome in Isfahan, Iran.

Authors:  Behnaz Ansari; Keivan Basiri; Yeganeh Derakhshan; Farzaneh Kadkhodaei; Ali Asghar Okhovat
Journal:  Adv Biomed Res       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.